| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.06B | +20.5% |
| Cost of Revenue | $3.42B | +25.9% |
| Gross Profit | $6.64B | +17.9% |
| R&D Expense | $1.31B | +14.5% |
| SG&A Expense | $2.38B | +11.4% |
| Operating Income | $2.95B | +25.4% |
| Pre-tax Income | $3.31B | +23.8% |
| Income Tax | $434.8M | +29.3% |
| Net Income | $2.86B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.37B | +66.1% |
| Short-term Investments | $2.57B | +29.3% |
| Accounts Receivable | $1.53B | +24.6% |
| Inventory | $1.84B | +23.7% |
| Current Assets | $9.78B | +37.5% |
| Total Assets | $20.46B | +9.2% |
| Current Liabilities | $2.01B | +14.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.03B | +25.5% |
| Investing Cash Flow | $665.8M | +120.3% |
| Financing Cash Flow | -$2.36B | -1666.7% |
| +23.0% |
| EPS (Basic) | $8.00 | +22.3% |
| EPS (Diluted) | $7.87 | +22.6% |
| Total Liabilities |
| $2.52B |
| +13.7% |
| Stockholders' Equity | $17.82B | +8.5% |